Suzuki F - Search Results

1

KF17837 ((E)-8-(3,4-dimethoxystyryl)-1,3-dipropyl-7-methylxanthine), a potent and selective adenosine A2 receptor antagonist.

Nonaka H, Ichimura M, Takeda M, Nonaka Y, Shimada J, Suzuki F, Yamaguchi K, Kase H. Nonaka H, et al. Among authors: suzuki f. Eur J Pharmacol. 1994 May 17;267(3):335-41. doi: 10.1016/0922-4106(94)90159-7. Eur J Pharmacol. 1994. PMID: 8088373

2

Photoisomerization of a potent and selective adenosine A2 antagonist, (E)-1,3-Dipropyl-8-(3,4-dimethoxystyryl)-7-methylxanthine.

Nonaka Y, Shimada J, Nonaka H, Koike N, Aoki N, Kobayashi H, Kase H, Yamaguchi K, Suzuki F. Nonaka Y, et al. Among authors: suzuki f. J Med Chem. 1993 Nov 12;36(23):3731-3. doi: 10.1021/jm00075a031. J Med Chem. 1993. PMID: 8246243 No abstract available.

3

KW-3902, a selective high affinity antagonist for adenosine A1 receptors.

Nonaka H, Ichimura M, Takeda M, Kanda T, Shimada J, Suzuki F, Kase H. Nonaka H, et al. Among authors: suzuki f. Br J Pharmacol. 1996 Apr;117(8):1645-52. doi: 10.1111/j.1476-5381.1996.tb15335.x. Br J Pharmacol. 1996. PMID: 8732272 Free PMC article.

4

8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors.

Shimada J, Suzuki F, Nonaka H, Ishii A. Shimada J, et al. Among authors: suzuki f. J Med Chem. 1992 Mar 6;35(5):924-30. doi: 10.1021/jm00083a018. J Med Chem. 1992. PMID: 1548682

5

(E)-1,3-dialkyl-7-methyl-8-(3,4,5-trimethoxystyryl)xanthines: potent and selective adenosine A2 antagonists.

Shimada J, Suzuki F, Nonaka H, Ishii A, Ichikawa S. Shimada J, et al. Among authors: suzuki f. J Med Chem. 1992 Jun 12;35(12):2342-5. doi: 10.1021/jm00090a027. J Med Chem. 1992. PMID: 1613758 No abstract available.

6

[Recent adenosine antagonists].

Suzuki F, Shimada J. Suzuki F, et al. Tanpakushitsu Kakusan Koso. 1995 Jul;40(10):1277-92. Tanpakushitsu Kakusan Koso. 1995. PMID: 7568926 Review. Japanese. No abstract available.

7

Possible physiological role of endogenous adenosine in defecation in rats.

Tomaru A, Ishii A, Kishibayashi N, Shimada J, Suzuki F, Karasawa A. Tomaru A, et al. Among authors: suzuki f. Eur J Pharmacol. 1994 Oct 13;264(1):91-4. doi: 10.1016/0014-2999(94)90641-6. Eur J Pharmacol. 1994. PMID: 7828649

8

KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity.

Kanda T, Shiozaki S, Shimada J, Suzuki F, Nakamura J. Kanda T, et al. Among authors: suzuki f. Eur J Pharmacol. 1994 May 2;256(3):263-8. doi: 10.1016/0014-2999(94)90551-7. Eur J Pharmacol. 1994. PMID: 8045270

9

Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease.

Kase H, Aoyama S, Ichimura M, Ikeda K, Ishii A, Kanda T, Koga K, Koike N, Kurokawa M, Kuwana Y, Mori A, Nakamura J, Nonaka H, Ochi M, Saki M, Shimada J, Shindou T, Shiozaki S, Suzuki F, Takeda M, Yanagawa K, Richardson PJ, Jenner P, Bedard P, Borrelli E, Hauser RA, Chase TN; KW-6002 US-001 Study Group. Kase H, et al. Among authors: suzuki f. Neurology. 2003 Dec 9;61(11 Suppl 6):S97-100. doi: 10.1212/01.wnl.0000095219.22086.31. Neurology. 2003. PMID: 14663020 Review.

10

Adenosine A1 antagonists. 3. Structure-activity relationships on amelioration against scopolamine- or N6-((R)-phenylisopropyl)adenosine-induced cognitive disturbance.

Suzuki F, Shimada J, Shiozaki S, Ichikawa S, Ishii A, Nakamura J, Nonaka H, Kobayashi H, Fuse E. Suzuki F, et al. J Med Chem. 1993 Aug 20;36(17):2508-18. doi: 10.1021/jm00069a009. J Med Chem. 1993. PMID: 8355252

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,652 results

Search Page